Publications by authors named "L M Frison"

Claim this Profile
U
Use of eGFR Slope Thresholds as End Point Components in a Kidney Disease Progression Hierarchical Composite End Point.
Niels Jongs, Samvel B Gasparyan, Lars Frison, Patrick Schloemer, Meike Brinker

J Am Soc Nephrol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial designs to assess treatment effects on glomerular filtration rate decline.
Hiddo J L Heerspink, Dustin J Little, Lars Frison, Samvel B Gasparyan, Christoph Wanner

Kidney Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements.
Massimiliano Bonifacio, Luigi Scaffidi, Maria Cristina Miggiano, Davide Facchinelli, Luca Tosoni, Luca Frison

Blood Cancer J· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review.
Dustin J Little, Samvel B Gasparyan, Patrick Schloemer, Niels Jongs, Meike Brinker, Lars Frison

J Am Soc Nephrol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study.
Steven Fishbane, Carol A Pollock, Mohamed El-Shahawy, Elizabeth T Escudero, Anjay Rastogi, Lars Frison

J Am Soc Nephrol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis